Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance
Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance
Active, not recruiting · NCT07568275 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Urogenital Diseases, acute kidney injury, cirrhosis of liver, kidney disorder, kidney failure, toxic shock syndrome, urinary system disorder | Active, not recruiting | Early phase 1 | 2026-05-05 | NCT07568275 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innoviva Specialty Therapeutics | 6 |
| The Cleveland Clinic | 239 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Cleveland Clinic | Cleveland | United States | 26 |